miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance
Authors
Keywords
miR-200c, Epithelial-mesenchymal transition (EMT), Drug resistance, TGF-β, ZEB1/2, Cell signaling, Biomarker
Journal
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume 94, Issue 6, Pages 629-644
Publisher
Springer Nature
Online
2016-04-20
DOI
10.1007/s00109-016-1420-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
- (2015) Yunching Chen et al. ADVANCED DRUG DELIVERY REVIEWS
- Effects of Decitabine on Invasion and Exosomal Expression of miR-200c and miR-141 in Oxaliplatin-Resistant Colorectal Cancer Cells
- (2015) Shota Tanaka et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features
- (2015) M. Zuberi et al. Clinical & Translational Oncology
- The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells
- (2015) Anamaria Brozovic et al. Molecular Oncology
- Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
- (2015) Kari R. Fischer et al. NATURE
- miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment
- (2015) Shujing Liu et al. Pigment Cell & Melanoma Research
- Increased Urinary Exosomal MicroRNAs in Patients with Systemic Lupus Erythematosus
- (2015) Javier Perez-Hernandez et al. PLoS One
- miR-200c dampens cancer cell migration via regulation of protein kinase A subunits
- (2015) Florian Christoph Sigloch et al. Oncotarget
- The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy
- (2015) Brock Humphries et al. Oncotarget
- LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer
- (2015) Sheng-Jia Shi et al. Oncotarget
- Prognostic markers in esophageal cancer: from basic research to clinical use
- (2015) Liu Hong et al. Expert Review of Gastroenterology & Hepatology
- A Long Noncoding RNA Activated by TGF-β Promotes the Invasion-Metastasis Cascade in Hepatocellular Carcinoma
- (2014) Ji-hang Yuan et al. CANCER CELL
- Regulation of Colorectal Carcinoma Stemness, Growth, and Metastasis by an miR-200c-Sox2-Negative Feedback Loop Mechanism
- (2014) Y.-X. Lu et al. CLINICAL CANCER RESEARCH
- MiR-200c inhibits autophagy and enhances radiosensitivity in breast cancer cells by targeting UBQLN1
- (2014) Quanquan Sun et al. INTERNATIONAL JOURNAL OF CANCER
- miR-205 and miR-200c: Predictive Micro RNAs for Lymph Node Metastasis in Triple Negative Breast Cancer
- (2014) Ufuk Berber et al. Journal of Breast Cancer
- MicroRNAs: master regulators of drug resistance, stemness, and metastasis
- (2014) Umar Raza et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25
- (2014) Jing Li et al. Molecular Cancer
- Ubiquitin ligase Cbl-b represses IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells
- (2014) Heming Li et al. Molecular Cancer
- Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy
- (2014) Carla L Esposito et al. MOLECULAR THERAPY
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Correction: Spectrums of Opportunistic Infections and Malignancies in HIV-Infected Patients in Tertiary Care Hospital, China
- (2014) Jiang Xiao et al. PLoS One
- miR-200c Regulates IL8 Expression by Targeting IKBKB: A Potential Mediator of Inflammation in Leiomyoma Pathogenesis
- (2014) Tsai-Der Chuang et al. PLoS One
- miR-141 and miR-200c as Markers of Overall Survival in Early Stage Non-Small Cell Lung Cancer Adenocarcinoma
- (2014) Rut Tejero et al. PLoS One
- Unlocking Doors without Keys: Activation of Src by Truncated C-terminal Intracellular Receptor Tyrosine Kinases Lacking Tyrosine Kinase Activity
- (2014) Belén Mezquita et al. Cells
- Serum miR-200c Is a Novel Prognostic and Metastasis-Predictive Biomarker in Patients With Colorectal Cancer
- (2013) Yuji Toiyama et al. ANNALS OF SURGERY
- Coordinated Regulation of β-Tubulin Isotypes and Epithelial-to-Mesenchymal Transition Protein ZEB1 in Breast Cancer Cells
- (2013) Sharon Lobert et al. BIOCHEMISTRY
- MiR-200c and HuR in ovarian cancer
- (2013) Silvia Prislei et al. BMC CANCER
- Acquired Resistance to EGFR Inhibitors Is Associated with a Manifestation of Stem Cell-like Properties in Cancer Cells
- (2013) K. Shien et al. CANCER RESEARCH
- Activation of miR200 by c-Myb depends on ZEB1 expression and miR200 promoter methylation
- (2013) Marco Pieraccioli et al. CELL CYCLE
- Enrichment of ovarian cancer stem-like cells is associated with epithelial to mesenchymal transition through an miRNA-activated AKT pathway
- (2013) X. Luo et al. CELL PROLIFERATION
- The Pitx2:miR-200c/141:noggin pathway regulates Bmp signaling and ameloblast differentiation
- (2013) H. Cao et al. DEVELOPMENT
- The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance
- (2013) Florian A. Siebzehnrubl et al. EMBO Molecular Medicine
- Isolation and Quantification of MicroRNAs from Urinary Exosomes/Microvesicles for Biomarker Discovery
- (2013) Lin-Li Lv et al. International Journal of Biological Sciences
- FOG2 Protein Down-regulation by Transforming Growth Factor-β1-induced MicroRNA-200b/c Leads to Akt Kinase Activation and Glomerular Mesangial Hypertrophy Related to Diabetic Nephropathy
- (2013) Jung Tak Park et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Truncated-Flt1 Isoform of Breast Cancer Cells Is Upregulated by Notch and Downregulated by Retinoic Acid
- (2013) Belén Mezquita et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- A p21-ZEB1 Complex Inhibits Epithelial-Mesenchymal Transition through the MicroRNA 183-96-182 Cluster
- (2013) X. L. Li et al. MOLECULAR AND CELLULAR BIOLOGY
- miRBase: annotating high confidence microRNAs using deep sequencing data
- (2013) Ana Kozomara et al. NUCLEIC ACIDS RESEARCH
- MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial–mesenchymal transition
- (2013) H Rajabi et al. ONCOGENE
- Elevated Serum Level of MicroRNA (miRNA)-200c and miRNA-371-5p in Children with Kawasaki Disease
- (2013) Ki Wook Yun et al. PEDIATRIC CARDIOLOGY
- Reduced Expression of miR-200 Family Members Contributes to Antiestrogen Resistance in LY2 Human Breast Cancer Cells
- (2013) Tissa T. Manavalan et al. PLoS One
- Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generation
- (2013) G. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- miR-200c and GATA binding protein 4 regulate human embryonic stem cell renewal and differentiation
- (2013) Hsiao-Ning Huang et al. Stem Cell Research
- Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo
- (2013) Sílvia Cufí et al. Scientific Reports
- miR-200c Inhibits Melanoma Progression and Drug Resistance through Down-Regulation of Bmi-1
- (2012) Shujing Liu et al. AMERICAN JOURNAL OF PATHOLOGY
- Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205
- (2012) Martin Puhr et al. AMERICAN JOURNAL OF PATHOLOGY
- Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer
- (2012) Casina WS Kan et al. BMC CANCER
- Diagnostic and prognostic potential of differentially expressed miRNAs between metastatic and non-metastatic renal cell carcinoma at the time of nephrectomy
- (2012) Zofia Wotschofsky et al. CLINICA CHIMICA ACTA
- Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer
- (2012) D. Madhavan et al. CLINICAL CANCER RESEARCH
- MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis
- (2012) Keun Hur et al. GUT
- Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma
- (2012) Naoki Oishi et al. HEPATOLOGY
- The role of MicroRNAs miR-200b and miR-200c in TLR4 signaling and NF-κB activation
- (2012) Erik B Wendlandt et al. Innate Immunity
- miR-200c enhances radiosensitivity of human breast cancer cells
- (2012) Jing Lin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Circulating MicroRNA in inflammatory bowel disease
- (2012) Archanioti Paraskevi et al. Journal of Crohns & Colitis
- A Unilateral Negative Feedback Loop Between miR-200 microRNAs and Sox2/E2F3 Controls Neural Progenitor Cell-Cycle Exit and Differentiation
- (2012) C. Peng et al. JOURNAL OF NEUROSCIENCE
- Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer
- (2012) Manuel Valladares-Ayerbes et al. Journal of Translational Medicine
- Restoration of miR-200c to Ovarian Cancer Reduces Tumor Burden and Increases Sensitivity to Paclitaxel
- (2012) D. M. Cittelly et al. MOLECULAR CANCER THERAPEUTICS
- IL6-Mediated Suppression of miR-200c Directs Constitutive Activation of Inflammatory Signaling Circuit Driving Transformation and Tumorigenesis
- (2012) Matjaz Rokavec et al. MOLECULAR CELL
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cooperation of p300 and PCAF in the Control of MicroRNA 200c/141 Transcription and Epithelial Characteristics
- (2012) Yoshiaki Mizuguchi et al. PLoS One
- miR-200c Targets a NF-κB Up-Regulated TrkB/NTF3 Autocrine Signaling Loop to Enhance Anoikis Sensitivity in Triple Negative Breast Cancer
- (2012) Erin N. Howe et al. PLoS One
- miR-200c Sensitizes Breast Cancer Cells to Doxorubicin Treatment by Decreasing TrkB and Bmi1 Expression
- (2012) Florian Kopp et al. PLoS One
- A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT
- (2011) J L Bryant et al. BRITISH JOURNAL OF CANCER
- RETRACTED: Notch-1 induces epithelial–mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells
- (2011) Bin Bao et al. CANCER LETTERS
- Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells
- (2011) Tissa T. Manavalan et al. CANCER LETTERS
- Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells
- (2011) B. Bao et al. Cancer Prevention Research
- ZEB proteins link cell motility with cell cycle control and cell survival in cancer
- (2011) Gareth Browne et al. CELL CYCLE
- Overexpression of miR-200c Induces Chemoresistance in Esophageal Cancers Mediated Through Activation of the Akt Signaling Pathway
- (2011) R. Hamano et al. CLINICAL CANCER RESEARCH
- miR-200c regulates FGFR-dependent epithelial proliferation via Vldlr during submandibular gland branching morphogenesis
- (2011) I. T. Rebustini et al. DEVELOPMENT
- Targeting Notch signalling by the conserved miR-8/200 microRNA family in development and cancer cells
- (2011) Diana M Vallejo et al. EMBO JOURNAL
- p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2
- (2011) Taewan Kim et al. JOURNAL OF EXPERIMENTAL MEDICINE
- miRNA Profiling for Clear Cell Renal Cell Carcinoma: Biomarker Discovery and Identification of Potential Controls and Consequences of miRNA Dysregulation
- (2011) Nicole M.A. White et al. JOURNAL OF UROLOGY
- Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections
- (2011) Sergio Marchini et al. LANCET ONCOLOGY
- High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer
- (2011) Xiao-Guang Liu et al. MEDICAL ONCOLOGY
- MicroRNA-200c Represses Migration and Invasion of Breast Cancer Cells by Targeting Actin-Regulatory Proteins FHOD1 and PPM1F
- (2011) S. Jurmeister et al. MOLECULAR AND CELLULAR BIOLOGY
- Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance
- (2011) Andreas Karakatsanis et al. MOLECULAR CARCINOGENESIS
- p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs
- (2011) Chun-Ju Chang et al. NATURE CELL BIOLOGY
- An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription
- (2011) Emily C. Knouf et al. NUCLEIC ACIDS RESEARCH
- The ZEB/miR-200 feedback loop—a motor of cellular plasticity in development and cancer?
- (2010) Simone Brabletz et al. EMBO REPORTS
- The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
- (2010) S. Leskela et al. ENDOCRINE-RELATED CANCER
- Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer
- (2010) Erik D. Wiklund et al. INTERNATIONAL JOURNAL OF CANCER
- Accurate Molecular Classification of Renal Tumors Using MicroRNA Expression
- (2010) Eddie Fridman et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Loss of miR-200c Expression Induces an Aggressive, Invasive, and Chemoresistant Phenotype in Non-Small Cell Lung Cancer
- (2010) P. Ceppi et al. MOLECULAR CANCER RESEARCH
- mir-200c Regulates Induction of Apoptosis through CD95 by Targeting FAP-1
- (2010) Robert Schickel et al. MOLECULAR CELL
- ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1
- (2010) E Sánchez-Tilló et al. ONCOGENE
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- Role for DNA Methylation in the Regulation of miR-200c and miR-141 Expression in Normal and Cancer Cells
- (2010) Lukas Vrba et al. PLoS One
- The microRNAs of Caenorhabditis elegans
- (2010) Ethan J. Kaufman et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Circulating tumour cells in cancer patients: challenges and perspectives
- (2010) Klaus Pantel et al. TRENDS IN MOLECULAR MEDICINE
- Therapeutic MicroRNA Strategies in Human Cancer
- (2009) Chunsheng Li et al. AAPS Journal
- Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells
- (2009) Y. Li et al. CANCER RESEARCH
- Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
- (2009) Yohei Shimono et al. CELL
- miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy
- (2009) L. Adam et al. CLINICAL CANCER RESEARCH
- Trk Receptor Expression and Inhibition in Neuroblastomas
- (2009) G. M. Brodeur et al. CLINICAL CANCER RESEARCH
- MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
- (2009) D. R. Cochrane et al. MOLECULAR CANCER THERAPEUTICS
- The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
- (2009) Ulrich Wellner et al. NATURE CELL BIOLOGY
- MicroRNAs as potential cancer therapeutics
- (2009) P Trang et al. ONCOGENE
- microRNA: Emerging therapeutic targets in acute ischemic diseases
- (2009) Pasquale Fasanaro et al. PHARMACOLOGY & THERAPEUTICS
- p21CIP1attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo
- (2009) Manran Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
- (2008) Ulrike Burk et al. EMBO REPORTS
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
- Most mammalian mRNAs are conserved targets of microRNAs
- (2008) R. C. Friedman et al. GENOME RESEARCH
- MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
- (2008) Douglas D. Taylor et al. GYNECOLOGIC ONCOLOGY
- The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional RepressorsZEB1andZEB2
- (2008) Manav Korpal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
- MicroRNA Discovery and Profiling in Human Embryonic Stem Cells by Deep Sequencing of Small RNA Libraries
- (2008) Merav Bar et al. STEM CELLS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now